PDE4A and asthma: Increasing the intracellular cAMP levels by PDE4 inhibition has been proven to be an effective strategy for the treatment of several inflammation diseases and after more than twenty years from the pioneering studies of Crummey, Thorphy and coworkers suggesting the potential of in asthma therapy, different molecules PDE4 inhibitors have been marketed.